QUOTIENT SCIENCES LIMITED offer service "Oncology"

Supports oncology drug development from candidate selection through commercial manufacture and supply. Over the past 5 years, Quotient has worked on more than 300 oncology development projects covering 91 different drug candidates across 34 disease indications, combining formulation expertise with an agile, flexible approach to clinical and commercial manufacturing. The approach covers pre-formulation assessment and formulation development, clinical development to accelerate proof of concept, formulation optimization and validation of human performance, process development and scale-up for Phase II/III clinical manufacturing, and commercial manufacturing and supply.